ENERPAC TOOL GROUP CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ENERPAC TOOL GROUP CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,149	1,096	1,183	655	493	529	571	598	590	617
Cost of revenue	746	356	358	362	276	286	306	303	288	305
Gross profit	403	260	283	293	217	243	265	295	301	312
Research and development	18.3	8.9	8.7	9.3	7.3	7.4	7.3	9	12.4	14.5
Selling, general and administrative				209	181	175	217	205	169	167
Operating income	-100	-84.9	50.2	47.5	24.2	51.1	30.7	83.9	122	133
Interest income	1.7	1.2	1.2	0.7	0.8	0.7	1.3	2.6	2.5	2.3
Other non-operating income	-1.36	-3.82	0.14	0.63	-2.89	-1.87	-2.28	-2.64	-2.54	-2.83
Pre-tax income	-130	-118	19.2	18.7	7.85	44	24	68.9	106	121
Income tax	-25.2	-22.6	14.5	10.7	2.29	3.76	4.4	15.2	23.3	28
Income from continuing operations	-105	-95.3	4.75	8.07	5.56	40.2	19.6	53.6	82.2	92.7
Net income	-105	-66.2	-21.6	-249	0.72	38.1	15.7	46.6	85.7	92.7
EBITDA	-52.4	-61.9	70.6	67.7	44.9	72.7	50.3	100	135	149
EPS, basic	-1.78	-1.11	-0.36	-4.07	0.01	0.63	0.26	0.82	1.58	1.72
EPS, diluted	-1.78	-1.11	-0.35	-4.04	0.01	0.63	0.26	0.82	1.56	1.70
Shares, basic (weighted)	59	59.4	60.4	61.2	60	60	59.5	56.7	54.3	54
Shares, diluted (weighted)	59	59.4	61	61.6	60.3	60.4	59.9	57.1	54.9	54.5
Dividend per share	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	180	230	250	211	152	140	121	154	167	152
Receivables	187	190	123	126	84.2	103	107	97.6	104	106
Inventory	131	144	72	77.2	69.2	75.3	83.7	74.8	72.9	78.8
Other current assets	45.5	61.7	32.5	30.5	35.6	38.5	31.3	28.8	27.9	39.7
Total current assets	543	647	1,047	730	341	357	342	356	372	376
Property, plant and equipment	114	94.5	55	56.7	61.4	48.6	41.4	39	40.3	53.3
Lease right-of-use assets					48.7	51.6	43.3	37.7	33	35.4
Goodwill	519	272	280	260	281	278	258	266	270	290
Intangible assets	239	220	71.7	52.4	62.4	54.5	41.5	37.3	36.1	46.9
Other non-current assets	23.2	24.9	31.2	24.4	78.2	82.1	74.1	64.2	59.1	61.7
Total assets	1,439	1,517	1,485	1,124	824	820	757	763	777	828
Accounts payable	115	133	69.6	76.9	45.1	62	72.5	50.5	43.4	42.9
Accrued liabilities	46.9	50.9	36	26.4	17.8	21.6	21.4	33.2	25.9	28.1
Short-term debt	18.8	30	30	7.5	0	0	0	3.75	5	7.5
Total current liabilities	242	379	354	300	106	135	153	148	129	137
Long-term debt	562	532	503	453	255	175	200	210	190	182
Lease liabilities					38.1	40.6	33.5	29.2	25.2	28.2
Other non-current liabilities	57.1	55.8	51.9	48	82.6	76.1	66.2	61.6	52.7	61.6
Total liabilities	918	1,016	927	823	465	408	439	436	385	394
Total debt	584	565	535	463	255	175	204	215	195	190
Paid-in capital	115	138	167	181	193	203	213	220	236	243
Retained earnings	1,260	1,191	1,167	915	918	953	967	1,011	262	284
Treasury stock	-618	-618	-618	-640	-668	-668	-743	-801	0
Other comprehensive income	-252	-227	-174	-172	-101	-93	-135	-121	-116	-104
Total equity	521	501	559	301	359	412	319	327	392	434
Total liabilities and equity	1,439	1,517	1,485	1,124	824	820	757	763	777	828

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-105	-66.2	-21.6	-249	0.72	38.1	15.7	46.6	85.7	92.7
Depreciation and amortization	47.8	22.9	20.4	20.2	20.7	21.6	19.6	16.3	13.3	15.7
Stock-based compensation	10.4	14.9	11.3	10.9	9.62	9.22	13.6	8.57	10.9	13
Deferred income tax	-17.4	-8.71	5.59	3.96	-7.82	9.64	-5.29	0.46	0.44	-0.19
Change in receivables	20.3	11.2	7.46	4.99	-44.7	-19.1	-23.8	5.17	-6.48	3.43
Change in inventory	10.2	-4.5	-1.14	-7.76	8.96	-5.86	-16	4.54	3.58	-3.21
Cash from operations	118	88.5	106	53.8	-3.16	54.2	51.7	77.6	81.3	111
Capital expenditures	-20.2	-17.2	-11	-14.9	-12.1	-12	-8.42	-9.4	-11.4	-19.3
Acquisitions	-81.9	0	-23.2	0	33.3	0	0	0	0	-26.7
Cash from investing	-83.1	-27.6	-62.8	11	176	13.3	-7.24	11.3	-13.9	-46
Debt issued						0	0	200
Debt repaid		-0.5	0	0
Stock issued	3.56	7.76	15.1	1.4	2.63	2.21	0	0.97	6.9
Share buybacks	-17.1	0	0	-22.5	-27.5	0	-75.1	-57.7	-38.4	-68.7
Dividends paid	-2.38	-2.36	-2.39	-2.44	-2.42	-2.39	-2.41	-2.27	-2.18	-2.17
Cash from financing	-18.4	-15.2	-18	-99.5	-239	-81.5	-52.2	-53.1	-56.3	-81.5
Exchange rate effect	-5.38	4.24	-4.43	-4.71	7.03	2.21	-11.9	-2.1	1.57	0.64
Net change in cash	10.8	50	20.9	-39.3	-59	-11.8	-19.7	33.7	12.7	-15.5
Free cash flow	97.5	71.3	95.1	38.9	-15.2	42.2	43.3	68.2	69.9	91.9
Interest paid	27.2	27.1	28.8	26.3	18.7	3.7	3.1	10.6	12.4	8.8
Income taxes paid	21.4	11.8	-1.5	15.4	13.2	7.8	5.7	2.7	23.8	26.6

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $35.70 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	50.1%	Gross profit / revenue.
Operating margin	21.2%	Operating income / revenue.
EBITDA margin	24.1%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	19.4%	Pre-tax income / revenue.
Net margin	14.7%	Net income / revenue.
FCF margin	17.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	19.6%	Cash from operations / revenue.
Effective tax rate	24.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	11.5%	Net income / average total assets.
SG&A / revenue	27.3%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	2.0%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	4.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	2.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.6%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.6%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	9.8%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	63.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	40.7%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	10.6%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	43.7%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	27.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	8.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	80.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	164.0%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	9.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	87.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	179.3%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	36.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	29.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow growth, 1y	31.5%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	28.5%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share growth, 1y	0.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	0.0%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	0.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	6.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-3.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-2.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.67x	Current assets / current liabilities.
Quick ratio	1.65x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.86x	(Cash + short-term investments) / current liabilities.
Debt / assets	22.8%	Total debt / total assets.
Liabilities / assets	47.8%	Total liabilities / total assets.
Net debt	$69.3M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.45x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$224.2M	Current assets - current liabilities.
Goodwill and intangibles / assets	41.1%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.78x	Revenue / average total assets.
Fixed asset turnover	11.6x	Revenue / average property, plant and equipment.
Inventory turnover	3.72x	Cost of revenue / average inventory.
Days inventory	98 days	365 x average inventory / cost of revenue.
Receivables turnover	5.99x	Revenue / average receivables.
Days sales outstanding	61 days	365 x average receivables / revenue.
Days payables	44 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	115 days	Days inventory + days sales outstanding - days payables.
FCF conversion	120.3%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	9.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.81	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$12.30	Revenue / diluted weighted shares.
FCF per share	$2.18	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.41	Cash from operations / diluted weighted shares.
Cash per share	$2.24	(Cash + short-term investments) / shares outstanding.
Payout ratio	2.3%	Dividends paid / net income, when net income is positive.
Dividends / FCF	1.9%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	108.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.83B	Share price x shares outstanding.
Enterprise value	$1.89B	Market cap + total debt - cash - short-term investments.
P/E	19.6x	Market cap / net income. Only when net income is positive.
P/S	2.88x	Market cap / revenue.
P/FCF	16.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	14.7x	Market cap / cash from operations, when positive.
EV/Sales	2.99x	Enterprise value / revenue.
EV/EBIT	14.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	12.4x	Enterprise value / EBITDA, when both are positive.
EV/FCF	16.9x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.2%	Free cash flow / market cap.
Earnings yield	5.1%	Net income / market cap (the inverse of P/E).
Dividend yield	0.1%	Dividends paid over the period / market cap.
Shareholder yield	6.8%	(Dividends paid + share buybacks) / market cap.
PEG	0.22x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ENERPAC TOOL GROUP CORP's revenue in fiscal 2025?

ENERPAC TOOL GROUP CORP reported revenue of $616.9M for fiscal 2025, 4.6% higher than the year before.

Was ENERPAC TOOL GROUP CORP profitable in fiscal 2025?

Yes. Net income was $92.7M, a net margin of 15%.

How much free cash flow did ENERPAC TOOL GROUP CORP generate in fiscal 2025?

Cash from operations of $111.3M minus capital expenditures of $19.3M left free cash flow of $91.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ENERPAC TOOL GROUP CORP